Key result
CD8+ effector memory T cell expansion is linked to ~20% higher odds of incident carotid plaque.
Why the study?
Do baseline levels and 3-year longitudinal dynamics of T cell subsets (such as CD8+ effector memory T cells and regulatory T cells) and endothelial markers predict incident subclinical carotid atherosclerotic plaque formation in healthy older adults?
Cohort (n=49)
Single-blinded reader for carotid ultrasound IMT analysis
No
Do baseline levels and 3-year longitudinal dynamics of T cell subsets (such as CD8+ effector memory T cells and regulatory T cells) and endothelial markers predict incident subclinical carotid atherosclerotic plaque formation in healthy older adults?
Answers are grounded in this paper and cite their sources.
Phase-dependent adaptive immune remodeling—specifically baseline VCAM-1 elevation and longitudinal expansion of CD8+ effector memory T cells alongside declining regulatory T cells—independently predicts early subclinical carotid plaque formation in healthy older adults better than traditional cardiometabolic risk factors.
Abstract Background Subclinical atherosclerotic plaque (SAP) develops silently in older adults. Early biological changes that predict plaque formation are not well defined. We examined whether immunological, and metabolic or functional measures identify vascular vulnerability before clinical disease. Methods In a three-year longitudinal study, 49 healthy older adults (63.8 ± 3.8 years) underwent carotid ultrasound, T cell phenotyping, serum protein profiling, body composition assessment, and fitness testing at baseline and follow up. At follow up, participants were classified as no SAP, new SAP or persistent SAP. We analyzed baseline determinants and within person changes to predict incident plaque formation. Results New SAP occurred in 30.3% of those initially plaque-free. At baseline, lower frequencies of CD8 ⁺ effector memory (EM) T cells and higher frequencies of CD8 ⁺ effector memory re-expressing CD45RA (EMRA) T cells and regulatory T cells (Tregs) were associated with higher odds of new SAP. Over time, expansion of CD8 ⁺ EM T cells was the strongest independent predictor of new SAP, accompanied by declines in Tregs and in the Treg/Teff ratio. Vascular cell adhesion molecule-1 (VCAM-1) at baseline was an additional independent predictor. Increases in visceral fat and declines in VO ₂ peak were linked to new SAP, but immune markers were more robust than metabolic variables or serum cytokines. Conclusion Adaptive immune remodeling follows a phase dependent pattern in which early CD8 ⁺ EM reductions and later CD8 ⁺ EM expansion with Treg decline signal emerging vascular vulnerability. These immune signatures, together with VCAM-1, may improve early plaque risk prediction.
No takes yet. Share an insight, caveat, or question.
Weyh et al. (2026) conducted a cohort in Subclinical atherosclerotic plaque (SAP) in healthy aging (n=49). Longitudinal CD8+ effector memory (EM) T cell expansion (ΔCD8+ EM) and baseline immune/endothelial profiling vs. Stable immune profile / participants remaining free of subclinical atherosclerotic plaque (no SAP) was evaluated on Incident subclinical atherosclerotic plaque (new SAP, defined as carotid intima-media thickness ≥1.5 mm) at 3-year follow-up among initially plaque-free participants (30.3% incidence; 10/33) (OR 1.20, 95% CI 1.00-1.46, p=0.048). Longitudinal expansion of CD8+ effector memory T cells independently predicted incident subclinical carotid plaque over 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: